Table 1 Mean relative abundance of different taxa at phylum level.

From: Loading ceftriaxone, vancomycin, and Bifidobacteria bifidum TMC3115 to neonatal mice could differently and consequently affect intestinal microbiota and immunity in adulthood

Stage

Phylum

Control

Ceftriaxone

Vancomycin

TMC3115

Ceftri + TMC3115

Vanco + TMC3115

PND21

Actinobacteria

0.02%

1.72%**

<0.01%

0.08%

12.36%**

0.14%

Bacteroidetes

65.71%

5.38%***

0.15%**

78.26%*

1.08%***

0.11%**

Firmicutes

27.39%

71.01%**

29.2%

12.34%**

83.39%**

28.77%

Proteobacteria

5.60%

21.17%*

70.64%***

8.92%

3.00%

70.98%***

PND56

Actinobacteria

0.18%

0.05%

0.36%

0.24%

<0.01%

<0.01%

Bacteroidetes

79.33%

43.30%***

58.55%***

38.33%***

63.96%***

57.33%***

Deferribacteres

0.04%

0.01%

1.62%*

0.21%

<0.01%

0.04%

Firmicutes

15.52%

48.29%**

37.41%**

57.20%**

25.58%*

28.64%**

Proteobacteria

3.53%

4.18%

1.72%

2.47%

6.23%

9.16%**

Verrucomicrobia

0.80%

4.03%

0.01%

0.35%

3.57%*

4.77%*

  1. n = 4/group; *p < 0.05, **p < 0.01, ***p < 0.001, comparing with control. TMC3115, Bifidobacterium bifidum TMC3115; Ceftri, Ceftriaxone; Vanco, Vancomycin; PND, postnatal day.
Back to article page